Cargando…

Safety of Intranasal Insulin in Type 2 Diabetes on Systemic Insulin: A Double-Blinded Placebo-Controlled Sub-Study of Memaid Trial

AIMS: To determine safety of intranasal insulin (INI) in MemAID trial participants with diabetes treated with systemic insulins. MATERIALS AND METHODS: This randomized, double-blinded trial consisted of 24-week INI or placebo treatment once daily and 24-week follow-up. Safety outcomes were: 1) Short...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aponte Becerra, L, Galindo Mendez, B, Khan, F, Lioutas, V, Novak, P, Mantzoros, CS, Ngo, LH, Novak, V
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9328174/ https://www.ncbi.nlm.nih.gov/pubmed/35903156

Ejemplares similares

MemAID: Memory advancement with intranasal insulin vs. placebo in type 2 diabetes and control participants: a randomized clinical trial
por: Novak, Vera, et al.
Publicado: (2022)

Intranasal insulin neuroprotection in ischemic stroke
por: Lioutas, Vasileios-Arsenios, et al.
Publicado: (2016)

Depressive symptoms exacerbate disability in older adults: A prospective cohort analysis of participants in the MemAID trial
por: Buss, Stephanie S., et al.
Publicado: (2022)

Safety and preliminary efficacy of intranasal insulin for cognitive impairment in Parkinson disease and multiple system atrophy: A double-blinded placebo-controlled pilot study
por: Novak, Peter, et al.
Publicado: (2019)

Enhancement of Vasoreactivity and Cognition by Intranasal Insulin in Type 2 Diabetes
por: Novak, Vera, et al.
Publicado: (2014)

Is there an effect of intranasal insulin on development and behaviour in Phelan-McDermid syndrome? A randomized, double-blind, placebo-controlled trial
por: Zwanenburg, Renée J, et al.
Publicado: (2016)

Double-Blind Placebo-Controlled Pilot Investigation of the Safety of a Single Dose of Rapid-Acting Intranasal Insulin in Down Syndrome
por: Rosenbloom, Michael, et al.
Publicado: (2020)

Intranasal Insulin for Alzheimer’s Disease
por: Hallschmid, Manfred
Publicado: (2021)

The role of insulin sensitivity and intranasally applied insulin on olfactory perception
por: Edwin Thanarajah, Sharmili, et al.
Publicado: (2019)

Short‐term effects of canagliflozin on glucose and insulin responses in insulin dysregulated horses: A randomized, placebo‐controlled, double‐blind, study
por: Lindåse, Sanna, et al.
Publicado: (2023)

Ellagic Acid Effect on the Components of Metabolic Syndrome, Insulin Sensitivity and Insulin Secretion: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
por: Hidalgo-Lozada, Gladys Maribel, et al.
Publicado: (2022)

Effect of acute iron infusion on insulin secretion: A randomized, double-blind, placebo-controlled trial
por: Jaccard, Evrim, et al.
Publicado: (2022)

Insulin-like growth factor 1 in relation to prostate cancer and benign prostatic hyperplasia - reply to the letter from Cohen, Peehl and Rosenfeld
por: Mantzoros, CS, et al.
Publicado: (1998)

Intranasal Insulin Ameliorates Experimental Diabetic Neuropathy
por: Francis, George, et al.
Publicado: (2009)

Targeting Mediators of Smoking Persistence with Intranasal Insulin
por: Hamidovic, Ajna
Publicado: (2017)

Intranasal insulin in Alzheimer’s disease: Food for thought
por: Chapman, Colin D., et al.
Publicado: (2018)

Effects of Metformin on the Regulation of Free Fatty Acids in Insulin Resistance: A Double-Blind, Placebo-Controlled Study
por: Castro Cabezas, Manuel, et al.
Publicado: (2012)

Effect of intranasal esketamine on cognitive functioning in healthy participants: a randomized, double-blind, placebo-controlled study
por: Morrison, Randall L., et al.
Publicado: (2018)

Effect of Vitamin D Supplementation on Obesity‐Induced Insulin Resistance: A Double‐Blind, Randomized, Placebo‐Controlled Trial
por: Cefalo, Chiara M.A., et al.
Publicado: (2018)

Impact of empagliflozin added on to basal insulin in type 2 diabetes inadequately controlled on basal insulin: a 78‐week randomized, double‐blind, placebo‐controlled trial
por: Rosenstock, J., et al.
Publicado: (2015)

Ondansetron treatment reduces rotavirus symptoms—A randomized double-blinded placebo-controlled trial
por: Hagbom, Marie, et al.
Publicado: (2017)

Intranasal Insulin Enhances Postprandial Thermogenesis and Lowers Postprandial Serum Insulin Levels in Healthy Men
por: Benedict, Christian, et al.
Publicado: (2011)

Utility of intranasal Ketamine and Midazolam to perform gastric aspirates in children: a double-blind, placebo controlled, randomized study
por: Buonsenso, Danilo, et al.
Publicado: (2014)

Intranasal Ketamine for Depression in Adults: A Systematic Review and Meta-Analysis of Randomized, Double-Blind, Placebo-Controlled Trials
por: An, Dongjiao, et al.
Publicado: (2021)

Double-blind, placebo-controlled clinical evaluation of an Ayurvedic formulation (GlucoCare capsules) in non-insulin dependent diabetes mellitus
por: Sharma, R. K., et al.
Publicado: (2010)

Long-term treatment with metformin in obese, insulin-resistant adolescents: results of a randomized double-blinded placebo-controlled trial
por: van der Aa, M P, et al.
Publicado: (2016)

Rapid transport of insulin to the brain following intranasal administration in rats
por: Fan, Lir-Wan, et al.
Publicado: (2019)

Distribution of insulin in trigeminal nerve and brain after intranasal administration
por: Lochhead, Jeffrey J., et al.
Publicado: (2019)

Odor Sensitivity After Intranasal Insulin Application Is Modulated by Gender
por: Rodriguez-Raecke, Rea, et al.
Publicado: (2018)

Clinical effects of topical antifungal therapy in chronic rhinosinusitis: a randomized, double-blind, placebo-controlled trial of intranasal fluconazole
por: Hashemian, Farshad, et al.
Publicado: (2016)

Combining insulin with metformin or an insulin secretagogue in non-obese patients with type 2 diabetes: 12 month, randomised, double blind trial
por: Lund, Søren S, et al.
Publicado: (2009)

Assessment of single-dose benzodiazepines on insulin secretion, insulin sensitivity and glucose effectiveness in healthy volunteers: a double-blind, placebo-controlled, randomized cross-over trial [ISRCTN08745124]
por: Chevassus, Hugues, et al.
Publicado: (2004)

Effect of a Dual PPAR α/γ agonist on Insulin Sensitivity in Patients of Type 2 Diabetes with Hypertriglyceridemia- Randomized double-blind placebo-controlled trial
por: Jain, Nimisha, et al.
Publicado: (2019)

Genetic variation within IL18 is associated with insulin levels, insulin resistance and postprandial measures()
por: Smart, M.C., et al.
Publicado: (2011)

Topical Insulin Accelerates Wound Healing in Diabetes by Enhancing the AKT and ERK Pathways: A Double-Blind Placebo-Controlled Clinical Trial
por: Lima, Maria H. M., et al.
Publicado: (2012)

Salacia Extract Improves Postprandial Glucose and Insulin Response: A Randomized Double-Blind, Placebo Controlled, Crossover Study in Healthy Volunteers
por: Jeykodi, Shankaranarayanan, et al.
Publicado: (2016)

Efficacy and safety of empagliflozin as add‐on to insulin in Japanese patients with type 2 diabetes: A randomized, double‐blind, placebo‐controlled trial
por: Sone, Hirohito, et al.
Publicado: (2019)

The effects of citrulline supplementation on meta-inflammation and insulin sensitivity in type 2 diabetes: a randomized, double-blind, placebo-controlled trial
por: Abbaszadeh, Fatemeh, et al.
Publicado: (2021)

Effects of intranasal insulin application on the hypothalamic BOLD response to glucose ingestion
por: Opstal, Anna M. van, et al.
Publicado: (2017)

Intranasal Insulin Administration Does Not Affect LH Concentrations in Men with Diabetes
por: Dhindsa, Sandeep, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_gnk93jgdq50tfcp4j8tumgm1ah